Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

990
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
990
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

280
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
280
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

234
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
234
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.9K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.9K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

543
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
543

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Substantial early morbidity and incomplete left ventricular recovery in Takotsubo syndrome: A single-center cohort study.

International journal of cardiology·2026
Same author

A systematic review on deep learning in ventricular septal defect screening, diagnosis, and management.

Annals of pediatric cardiology·2026
Same author

Safety and Feasibility of a CT-Based Pathway for Left Atrial Appendage Assessment Prior to Inpatient Cardioversion: A Single-Center Experience.

Clinical cardiology·2026
Same author

Impact of routine urine sodium evaluation on diuretic practices in patients with acute heart failure.

ESC heart failure·2026
Same author

Haemodynamic phenotypes and clinical outcomes in patients with severe tricuspid regurgitation.

European heart journal. Cardiovascular Imaging·2026
Same author

Residual perfusion defects after acute pulmonary embolism: Prevalence, determinants, and clinical impact.

The American journal of medicine·2026

Related Experiment Video

Updated: Dec 31, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.6K

The Aspirin Primary Prevention Conundrum.

Miri Schamroth Pravda1,2, Nili Schamroth Pravda3,2, Yitzhak Beigel4,2

  • 1Department of Internal Medicine A, Meir Medical Center, Kfar Saba, Israel.

The Israel Medical Association Journal : IMAJ
|January 14, 2020
PubMed
Summary

This review examines aspirin's role in preventing cardiovascular disease. It analyzes current evidence for aspirin in primary prevention, especially for those with moderate risk, diabetes, or in older populations.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.3K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.7K

Related Experiment Videos

Last Updated: Dec 31, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.6K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.3K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.7K

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pharmacology

Background:

  • Aspirin has a long history in cardiovascular disease prevention.
  • Current guidelines and recent evidence are re-examined.
  • Focus on primary prevention strategies.

Purpose of the Study:

  • To re-evaluate aspirin's efficacy in primary cardiovascular disease prevention.
  • To analyze recent evidence in specific patient groups.
  • To inform clinical practice regarding aspirin use.

Main Methods:

  • Literature review of historical and recent studies.
  • Analysis of clinical trial data.
  • Synthesis of evidence for different risk populations.

Main Results:

  • Evidence synthesis on aspirin's benefits and risks in primary prevention.
  • Evaluation of aspirin use in moderate cardiovascular risk individuals.
  • Assessment of aspirin's role in diabetes mellitus and elderly populations.

Conclusions:

  • Aspirin's role in primary prevention requires careful consideration of individual risk.
  • Recent evidence may modify recommendations for specific populations.
  • Further research may refine optimal aspirin use strategies.